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Abstract
Background: Frailty is associated with multiple adverse outcomes in stage-5 chronic kidney disease (CKD-5) and
upwards of one third of people receiving haemodialysis (HD) are frail. While many frailty screening methods are
available in both uremic and non-uremic populations, their implementation in clinical settings is often challenged
by time and resource constraints. In this study, we explored the diagnostic accuracy of time-efficient screening
tools in people receiving HD.
Methods: A convenience sample of 76 people receiving HD [mean age = 61.1 years (SD = 14), 53.9% male] from
three Renal Units were recruited for this cross-sectional study. Frailty was diagnosed by means of the Fried
phenotype. Physical performance-based screening tools encompassed handgrip strength, 15-ft gait speed, timed up
and go (TUG), and five-repetition sit to stand (STS-5) tests. In addition, participants completed the SF-36 Health
Survey, the short-form international physical activity questionnaire and the Tinetti falls efficacy scale (FES) as further
frailty-related measures. Outcome measures included the area under the curve (AUC), sensitivity, specificity, positive
(PPV) and negative predictive values (NPV). The diagnostic performance of screening tools in assessing fall-risk was
also investigated.
Results: Overall, 36.8% of participants were classified as frail. All the examined instruments could significantly
discriminate frailty status in the study population. Gait speed [AUC = 0.89 (95%CI: 0.81–0.98), sensitivity = 75%,
specificity = 93%] and TUG [AUC = 0.90 (95%CI: 0.80–0.99), sensitivity = 89%, specificity = 85%] exhibited the highest
diagnostic accuracy. There was a significant difference in gait speed AUC (20%, p = 0.013) between participants
aged 65 years or older (n = 36) and those under 65 years of age (n = 40), with better discriminating performance in
the younger sub-group. The Tinetti FES was the only instrument showing good diagnostic accuracy (AUCs≥0.80) for
both frailty (sensitivity = 82%, specificity = 79%) and fall-risk (sensitivity = 82%, specificity = 71%) screening.
Conclusions: This cross-sectional study revealed that time- and cost-efficient walking performance measures can
accurately be used for frailty-screening purposes in people receiving HD. While self-selected gait speed had an
excellent performance in people under 65 years of age, TUG may be a more suitable screening method for elderly
patients (≥65 years). The Tinetti FES may be a clinically useful test when physical testing is not achievable.
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Background
Frailty is a biological syndrome of decreased reserve and
resistance to stressors, resulting from cumulative de-
clines across multiple physiologic systems, and causing
vulnerability to adverse outcomes [1]. Chronic kidney
disease (CKD) promotes the activation of multiple pro-
ageing pathways, which can lead to an early onset of
frailty and increase the risks for morbidity and mortality
[2]. Progression to stage-5 chronic kidney disease (CKD-
5) is associated with further worsening of physical func-
tion and frailty-related outcomes [3]. Several observa-
tional studies have consistently concluded that upwards
of one third of people receiving haemodialysis (HD)
meet diagnostic criteria for frailty [4]. In the context of
CKD-5-HD, frailty has been associated with multiple ad-
verse outcomes such as loss of functional independence,
falls, hospitalisations, cognitive impairment, vascular ac-
cess complications, lower chances of receiving a kidney
transplant and increased risk of mortality [5–9].
Despite the overwhelming clinical implications of frailty,
appropriate screening is still not routinely performed in
many HD Units [10]. Several screening tools have been
proposed and validated in at-risk populations living with
or without CKD [11, 12]. However, the two most common
operationalisations of frailty are the Fried phenotype [1]
and the deficit accumulation model, as assessed through
the Frailty Index [13]. While both approaches have their
unique strengths, the Fried phenotype remains the de
facto gold standard [14] due to its earlier introduction and
greater evidence in terms of predicting negative health
outcomes in CKD [15]. Although the Fried phenotype is a
relatively expedient assessment, it requires a combination
of both physical measures and questionnaires. For this
reason, many clinicians still find this procedure time-
consuming and potentially unpractical in the context of
renal outpatient services [12]. To overcome this imple-
mentability issue, several researchers have designed alter-
native operationalisations of the Fried phenotype by
replacing the performance-based measures with subjective
(questionnaire-based) assessments in both CKD [16] and
non-CKD populations [17, 18]. Although these self-
reported definitions of frailty perform well in predicting
adverse outcomes [5], they are often less accurate than ob-
jective assessments of physical performance in diagnosing
frailty in people living with CKD-5 [12, 16]. Therefore,
while self-reported measures remain advantageous from a
practical standpoint, there is also a need to identify object-
ive measures of physical performance which could be con-
veniently utilised, as an alternative to the Fried phenotype,
in renal outpatient services. In this regard, several “field”
performance-based tests such as gait speed, timed up and
go, and repeated chair stands are commonly employed to
assess physical function in CKD [19] and may represent a
viable solution.
Assessing frailty in HD is becoming increasingly im-
portant due to the rapid ageing of dialysis populations
[20]. Early identification of frailty may be a valuable
strategy to improve overall outcomes, while repeated as-
sessments over time can provide useful prognostic infor-
mation and assist both nephrologists and patients in
better understanding the risks and benefits of dialysis
continuation in frail individuals [10, 14]. The emerging
need to routinely and accurately evaluate frailty is ac-
companied by the call for identification of screening
tools that are less time-intensive (compared to reference
standards), easily implementable in HD settings, and
predictive of multiple frailty-related outcomes [16].
Therefore, the objective of this study was to explore the
diagnostic accuracy of several frailty screening methods,
using the Fried phenotype as reference standard, in
people receiving HD. As a secondary objective, we ex-
amined the diagnostic accuracy of the proposed methods
in predicting fall-risk, often a corollary of frailty, within
the same population.
Methods
Study design and setting
A cross-sectional study design was used to explore the diag-
nostic accuracy of frailty-related screening tools (e.g. object-
ive and subjective measures of physical function), utilising
the Fried phenotype as reference standard, in a convenience
sample of people receiving HD. The study was conducted in
three Renal Units located in Fife and North Lanarkshire,
United Kingdom, between October 2015 and August 2018
(trial registration ID: NCT02392299). All frailty-related and
clinical measures were collected during a single assessment,
which was performed by a trained researcher on a non-
dialysis day (during the midweek interval). The study con-
formed to the ethical principles for medical research involv-
ing human participants, as outlined by the world medical
association declaration of Helsinki, and received ethical ap-
proval by the Queen Margaret University and West of
Scotland NHS Research Ethics Committees (NHS REC refer-
ence number: 15/WS/0079).
Study participants
A convenience sample of prevalent CKD-5 patients receiving
HD therapy was recruited for this study. Inclusion criteria
were: 1) HD vintage of at least 3months, 2) good under-
standing of spoken and written English, and 3) aged 18 years
or older. Patients were not considered eligible if they had 1)
lower limb amputation without prosthesis, 2) unstable car-
diovascular conditions (i.e. clinically severe left ventricular
outflow obstruction, suspected or known aneurysm, critical
mitral stenosis, critical cerebrovascular stenosis, critical prox-
imal coronary artery stenosis), 3) unstable dialysis and medi-
cation treatment, 4) severe cognitive impairment (defined by
clinical diagnoses ascertained through medical records, e.g.
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dementia, Alzheimer’s disease), and 5) pregnancy. People
who agreed to take part in the study provided written in-
formed consent prior to participation.
Data collection procedures
Demographics (i.e. age, gender) and clinical characteristics
(i.e. HD vintage, Charlson comorbidity index, number of
medications and laboratory values) were extracted from the
participants’ medical records. Height, weight and body mass
index were measured on the assessment day. Falls were oper-
ationally defined according to the Prevention of Falls Network
Europe (ProFaNE) recommendations as unexpected events in
which the participant comes to rest on the ground, floor, or
lower level [21]. We utilised a customised falls questionnaire
to prospectively record falls for 12months. A trained re-
searcher administered this questionnaire to participants once
a month, during their dialysis sessions [22]. Participants were
classified at-risk of falling if they 1) experienced at least one
fall during the prospective follow-up, or 2) reported at least
two falls in the previous year [23, 24].
Frailty was operationalised by means of the Fried
phenotype [1], which assesses the five canonical compo-
nents of unintentional weight loss, exhaustion, weakness,
slow walking speed and low levels of physical activity.
These components were defined as: 1) unintentional
weight loss ≥10 lbs. in the previous year (ascertained
through medical records), 2) self-reported exhaustion,
assessed by means of the SF-36 questionnaire (vitality
score <55) [25], 3) low strength, assessed through an iso-
metric handgrip test below an established threshold [1],
4) low gait speed, assessed as time to walk 15 ft above an
established threshold [1], and 5) low self-reported levels
of physical activity, assessed by means of the short-form
international physical activity questionnaire (IPAQ-SF)
[26] (total Kcal/week below an established threshold
[1]). Participants were classified as frail if they met at
least three of these components [1, 27]. Among non-frail
participants, individuals who met one or two criteria
were classified as pre-frail, while those not meeting any
criteria were considered robust.
Participants completed a battery of physical function
tests including the handgrip test, 15-ft walking test,
three-metre timed up and go (TUG) test, and five-
repetitions sit to stand test (STS-5), which were used as
frailty screening tools [11, 12]. Maximal isometric hand-
grip strength was measured, as part of the Fried pheno-
type, by means of a hydraulic hand dynamometer (Jamar
Patterson Medical Ltd., USA) in the seated position with
the elbow flexed at 90 degrees and the forearm in the
neutral position: participants performed three trials with
the dominant arm, interspersed by a one-minute rest,
and the average of these was taken for analysis [28]. The
15-ft walking test was used to assess gait speed (m/s) [1].
The beginning and ending of the 15-ft track (4.57 m)
were marked with adhesive tape, and a stopwatch was
used to record the time. Participants were instructed to
walk with their normal walking pace and were allowed
to use their assistive walking devices (e.g. cane) if neces-
sary. Two trials interspersed by a 30-s rest were per-
formed and the average was taken for data analysis. For
the TUG test, participants were asked to stand up from
a chair, walk three metres, turn, walk back to the chair
and sit down again, as quickly as possible [29]. This test
was executed twice and up to 60 s of rest were allowed
between the two measurements. The average time to
perform the two trials was calculated for data analysis
[30]. Finally, participants performed the STS-5 test as a
further measure of lower limb muscle power [31]. The
time required to rise from a chair repeatedly five times,
as quickly as possible was recorded [32]. One trial
rounded to the hundredth of a second was taken for
data analysis.
Participants were also administered the SF-36 Health
Survey 2.0, the IPAQ-SF and the Tinetti Falls Efficacy
Scale (FES) as further frailty-related measures [33–35]
by the trained researcher. The SF-36 is a validated tool
for the assessment of health-related quality of life in
both CKD and non-CKD populations [36]. This survey
evaluates eight domains of health: physical functioning,
role limitations due to physical health problems, bodily
pain, general health, vitality, social functioning, role limi-
tations due to emotional problems, and mental health
[37]. Participants completed the SF-36 and their answers
to the questions were transformed to create scores (ran-
ging from 0 to 100) for each domain, using appropriate
SPSS syntaxes. Physical and mental composite scores
were also calculated as per standard procedures [37].
The scores from the physical functioning domain (SF-36
PF) and the physical component summary (SF-36 PCS)
were taken for analysis [33]. The IPAQ-SF is a four-item
questionnaire asking about frequency and duration of
walking activities, moderate- and vigorous-intensity ac-
tivities, and sedentary behaviour (average daily sitting-
time) in the last 7 days [26]. The frequency and duration
of these activities were initially entered as ‘days’ and ‘mi-
nutes’, which were subsequently converted to MET-
minutes/week by using a physical activity compendium,
as per standard procedures [38]. Finally, participants
were administered the Tinetti FES, a 10-item rating scale
assessing perceived levels of confidence in undertaking a
range of activities of daily living (ADL) without fear of
falling [39]. Participants were asked to rate their confi-
dence from one to 10 for each ADL, with higher scores
indicating worse confidence and higher fear of falling.
Statistical analysis
Statistical analyses were performed with SPSS (Version 26
for Windows, SPSS Inc., Chicago, IL). The Kolmogorov-
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Smirnov test was used to assess whether data were normally
distributed. Demographic and clinical characteristics were
summarised as mean ± standard deviation or median and
interquartile range based on normal distribution assump-
tions. Individual missing items were handled with pairwise
deletion in the analysis. Differences between frail and non-
frail participants were explored by means of Independent t-
tests and Mann-Whitney U for continuous variables, as ap-
propriate, or through Chi-square tests/Fisher’s exact test for
categorical variables. Receiver operating characteristic (ROC)
analysis was used to explore the diagnostic accuracy of
screening tools through the area under the curve (AUC).
Classifier evaluation metrics included the Gini Index, the KS
statistic, and test cut-offs along with their sensitivity/specifi-
city. The positive/negative predictive (PPV/NPV) values and
likelihood ratios (LR) were also determined. In a further ana-
lysis, we explored the diagnostic accuracy of the screening
tools categorised by age (< 65 years old and ≥ 65 years old)
and we compared the AUCs in the two age groups. Add-
itional ROC analyses were performed to explore the diagnos-
tic performance of the screening tools, as well as the Fried
phenotype, in assessing fall-risk. Statistical limits for inter-
pretation of all analyses were set at an alpha level of 0.05.
Results
Study participants
Seventy-six people [mean age = 61.1 years (SD = 14),
53.9% male] undergoing outpatient HD therapy at the
Renal Units volunteered to take part in this cross-
sectional study. Overall, 28 participants (36.8%) were
classified as frail using the Fried phenotype descriptions.
The remaining 48 participants (63.2%) were classified as
non-frail, with 42 (55.3%) and six (7.9%) meeting the cri-
teria for pre-frailty and robustness respectively. The
demographic and clinical characteristics of frail and
non-frail participants are summarised in Table 1. Those
who were frail had higher age, Charlson comorbidity
index, number of prescribed medications, a higher pro-
portion of falls and lower levels of albumin and creatin-
ine compared to their non-frail counterparts (Table 1).
Two participants (2.6%) did not provide complete an-
swers to the SF-36 questionnaire and were therefore ex-
cluded from the calculation of the PF and PCS
subscales. One (1.3%), two (2.6%) and five (6.6%) frail
participants were unable to perform the gait speed, TUG
and STS-5 tests, respectively.
Frailty screening tools
Individual value plots of the frailty screening tools data
among robust, pre-frail and frail participants are shown
in Figs. 1 and 2. The diagnostic accuracies of the screen-
ing tools are summarised in Table 2. Overall, gait speed
and TUG had the highest AUC values (0.89 [95%CI:
0.81–0.98] and 0.90 [95%CI: 0.80–0.99]), with gait speed
having the highest PPV (0.86) and LR+ (10.14), and
TUG having the highest NPV (0.93) and lowest LR-
(0.13). Among screening tools that were not based on
physical performance, the IPAQ-SF and Tinetti FES had
the greatest diagnostic accuracy (AUC = 0.84 [95%CI:
0.75–0.94] and AUC = 0.84 [95%CI: 0.74–0.94]). A cut-
off value of ≤99 METS/min/week (total physical activity)
in the IPAQ-SF had excellent sensitivity (90%) but only
fair specificity (71%), while a cut-off value of ≥21 in the
Tinetti FES had both good sensitivity (82%) and specifi-
city (79%).
The diagnostic accuracy of the frailty screening tools cate-
gorised by age are summarised in Table 3. Overall, the diag-
nostic accuracies were comparable for most tools in the < 65
years-old (n= 40) and ≥ 65 years-old (n= 36) sub-groups,
with differences in AUCs ranging from 0.02 to 0.11 (p-
values≥0.277). However, there was a significant difference in
AUC for gait speed (0.20 [95%CI: 0.04–0.35], p= 0.013), with
a better performance of this test in the < 65 years-old sub-
group (0.98 [95%CI: 0.96–1.00]) compared to the ≥65 years-
old (0.79 [95%CI: 0.64–0.94]). Additionally, while the AUC
values of the handgrip were similar in both sub-groups, this
Table 1 Demographic and clinical characteristics of study
participants: results are expressed as percentages for categorical







Gender, female, n (%) 11 (39.3) 24 (50) 0.366
Age (years) 66.5 ± 10.5 57.9 ± 14.9 0.009
BMI (kg * m−2) 28.6 ± 6.3 29.2 ± 6.4 0.672
Dialysis vintage (days) 449 [881] 497 [891] 0.690
CCI (score) 6 ± 2.1 4.8 ± 2.3 0.032
Diabetes mellitus, n (%) 9 (32.1) 11 (22.9) 0.378
Vascular access type, n (%)
Arteriovenous fistula 15 (53.6) 35 (74.5) 0.063
Central-venous 13 (46.4) 12 (25.5) 0.063
Medications (n°) 13.3 ± 4.5 10.9 ± 2.9 0.015
History of falls, n (%) 16 (59.3) 17 (35.4) 0.046
Laboratory values
Hb (g/dL) 11.2 ± 1.1 11.2 ± 1.2 0.924
CRP (mg/L) 8 [24] 6 [8] 0.075
Phosphate (mmol/L) 1.3 ± 0.5 1.5 ± 0.6 0.084
PTH (ρmol/L) 24 [19.4] 19.1 [16.8] 0.177
Albumin (g/L) 36.5 [5.8] 38 [4] 0.015
Adjusted calcium (mmol/L) 2.4 ± 0.1 2.3 ± 0.1 0.475
URR (%) 70.8 ± 7 71.5 ± 5.4 0.635
Creatinine (μmol/L) 555 ± 147 680 ± 150 0.001
Abbreviations: SD Standard deviation, IQR Interquartile range, BMI Body mass
index, CCI Charlson comorbidity index, HD Haemodialysis, Hb Hemoglobin, CRP
C-reactive protein, PTH Parathyroid hormone, URR Urea reduction ratio
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test did not significantly discriminate frail from non-
frail individuals in those aged under 65 years (0.66
[95%CI: 0.46–0.86]).
Fall-risk screening
Table 4 illustrates the diagnostic accuracy of the exam-
ined screening tools for the assessment of fall-risk. Over-
all, the handgrip, gait speed, TUG, SF-36 and the Tinetti
FES could significantly discriminate participants with
history of falls from those without falls. The AUC values
of handgrip, gait speed, TUG and SF-36 ranged from
0.65 (95%CI: 0.52–0.78) to 0.69 (95%CI: 0.57–0.81), indi-
cating a poor to fair diagnostic value. The Tinetti FES
exhibited good diagnostic accuracy (AUC = 0.80 [95%CI:
0.69–0.90], p < 0.001), with a cut-off value ≥18 having
good sensitivity (82%) and fair specificity (71%). On the
other hand, the Fried phenotype did not significantly
discriminate fall-risk in the study population (AUC =
0.61 [95%CI: 0.48–0.74], p = 0.093).
Discussion
In this study, we explored the diagnostic accuracy of se-
lected screening tools to expedite assessment of frailty in
people receiving HD, using the Fried phenotype as the
reference standard. Overall, all the examined methods
could significantly discriminate frail from non-frail indi-
viduals, with gait speed and TUG exhibiting the highest
AUC values and elevated PPV/NPV. While gait speed
had the highest specificity (93%) and PPV (0.86), TUG
had the highest NPV (0.93). As a secondary objective,
we explored the diagnostic accuracy of the same
methods for fall-risk screening. In this further analysis,
the Tinetti FES revealed the highest AUC value.
The prevalence of frailty in the study population was
36.8% which is strongly aligned with findings from a re-
cent meta-analysis on the prevalence of physical frailty
in CKD-5 [4]. Therefore, our findings seem to exhibit
external validity and may be generalised to the general
HD population. Among non-frail participants, only one
eighth were classified as robust, while the large majority
of patients met at least one of the criteria of the Fried
phenotype, which is also in agreement with previous re-
search [40, 41]. Although the mean age of frail partici-
pants (66.5 ± 10.5 years) in our sample was considerably
lower compared to community-dwelling participants
from the Cardiovascular Health Study [1], the prevalence
Fig. 1 Individual value plots of physical performance-based screening tools in frail and non-frail (robust and prefrail) participants. Legend: TUG:
timed up and go test; STS-5: five-seconds sit to stand test
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of frailty was about five-fold higher. This observation
may indirectly reflect the premature onset of frailty in
people living with CKD-5 [2].
Previous diagnostic accuracy studies employed a geri-
atric assessment [42], a frailty index [43], and the Fried
phenotype [12] to evaluate different frailty screening
methods in CKD-5 populations. These different choices
in terms of reference standards highlight the current
lack of consensus on an unequivocal definition of frailty.
While a comprehensive geriatric assessment is regarded
as the gold standard for the assessment of frailty in clin-
ical practice [44], the Fried phenotype has often been
Fig. 2 Individual value plots of questionnaire-based screening tools in frail and non-frail (robust and pre-frail) participants. Legend: SF-36 PF: physical function
score of SF-36 questionnaire; SF-36 PCS: physical composite scale of SF-36 questionnaire: IPAQ: international physical activity questionnaire (short format); FES:
Tinetti falls efficacy scale
Table 2 Diagnostic accuracy of screening tools to expedite assessment of frailty in people receiving haemodialysis
Screening tools AUC (95% CI) P-value Gini-I K-S Cut-off Prevalence, n (%) SENS SPEC PPV NPV LR+ LR-
Handgrip (Kg) 0.71 (0.59–0.83) 0.001 0.42 0.36 ≤ 21.17 18 (23.7) 90% 46% 0.49 0.89 1.67 0.22
Gait speed (m/s) 0.89 (0.81–0.98) < 0.001 0.78 0.68 ≤ 0.85 38 (50.7) 75% 93% 0.86 0.87 10.14 0.27
TUG (s) 0.90 (0.80–0.99) < 0.001 0.79 0.74 ≥ 10.88 30 (40.5) 89% 85% 0.76 0.93 6.06 0.13
STS-5 (s) 0.86 (0.75–0.96) <0.001 0.71 0.64 ≥ 15.65 30 (42.3) 87% 77% 0.64 0.93 3.80 0.17
SF-36 PF (score) 0.78 (0.67–0.89) < 0.001 0.56 0.49 ≤ 42.5 40 (54.1) 64% 85% 0.71 0.80 4.31 0.42
SF-36 PCS (score) 0.76 (0.64–0.88) < 0.001 0.52 0.47 ≤ 32.3 27 (37) 80% 67% 0.59 0.85 2.41 0.29
IPAQ (METs/min/week) 0.84 (0.75–0.94) < 0.001 0.68 0.61 ≤ 99 25 (32.9) 90% 71% 0.64 0.92 3.13 0.15
FES (score) 0.84 (0.74–0.94) < 0.001 0.68 0.61 ≥ 21 33 (43.4) 82% 79% 0.69 0.88 3.95 0.23
Abbreviations AUC Area under the curve, CI Confidence interval, Gini-I Gini Index, K-S KS statistic, SENS Sensitivity, SPEC specificity, PPV Positive predictive value,
NPV Negative predictive value, LR+ Positive likelihood ratio, LR- Negative likelihood ratio, TUG Timed up and go test, STS-5 Five-seconds sit to stand test, SF-36 PF
Physical function score of SF-36 questionnaire, SF-36 PCS Physical composite scale of SF-36 questionnaire, IPAQ International physical activity questionnaire (short
format), FES Tinetti falls efficacy scale
Zanotto et al. BMC Geriatrics          (2021) 21:411 Page 6 of 10
preferred due to its greater expediency and solid evi-
dence base in terms of predicting adverse outcomes. In
the study by van Loon et al., [42], 75 and 48% of partici-
pants were classified as frail according to a comprehen-
sive geriatric assessment, which was used as reference
standard, and to the Fried phenotype, respectively. It is
interesting to note how the discrepancy in frailty preva-
lence emerging from this study was most likely under-
scored by the different conceptualisations of frailty that
were employed. Indeed, the geriatric assessment utilises
a multidimensional approach to evaluate multiple com-
ponents of frailty (e.g. physical and cognitive function,
depression, malnutrition, comorbidities etc.) while the
Fried phenotype focuses primarily on physical frailty.
This important distinction should be kept in mind when
interpreting findings from our study. Interestingly, our
investigation presents similarities with the work by
Nixon et al., [12] in both study design (i.e. Fried pheno-
type used as the reference standard) and outcomes. In
agreement with this study, we found that gait speed had
an excellent diagnostic accuracy, with comparable AUC
(0.89 vs 0.97), PPV (0.86 vs 0.84) and NPV (0.87 vs 0.96)
values. In addition, gait speed performed better than
other commonly used performance-based screening
tools, such as handgrip strength [12]. Although the sam-
ple examined by Nixon et al., [12] predominantly in-
cluded pre-dialysis patients, our findings seem to
corroborate the authors’ conclusion that gait speed can
be used to accurately screen for frailty in CKD and, by
extension, in the dialysis population.
It is also noteworthy that, while gait speed had excel-
lent overall diagnostic accuracy, there was a significant
effect of aging on the observed AUC. Particularly, there
was a 20% difference in AUC between age groups, with
better performance in those under 65 years of age (Table
3). Since gait speed exhibited lower diagnostic accuracy
than TUG in the older group, we plausibly take the view
that TUG may be a more suitable screening method in
Table 3 Diagnostic accuracy of frailty screening tools according
to age group
Screening tools AUC (95% CI) P-value ΔAUC (95% CI) P-value
Handgrip
< 65 years 0.66 (0.46–0.86) 0.123 0.08 (−0.34–0.18) 0.564
≥ 65 years 0.73 (0.57–0.90) 0.006
Gait speed
< 65 years 0.98 (0.96–1.00) < 0.001 0.20 (0.04–0.35) 0.013
≥ 65 years 0.79 (0.64–0.94) < 0.001
TUG
< 65 years 0.95 (0.87–1.00) < 0.001 0.08 (−0.08–0.23) 0.350
≥ 65 years 0.87 (0.73–1.00) < 0.001
STS-5
< 65 years 0.92 (0.82–1.00) < 0.001 0.11 (−0.09–0.30) 0.277
≥ 65 years 0.81 (0.65–0.97) < 0.001
SF-36 PF
< 65 years 0.81 (0.67–0.96) < 0.001 0.03 (−0.18–0.24) 0.786
≥ 65 years 0.78 (0.63–0.94) < 0.001
SF-36 PCS
< 65 years 0.83 (0.66–0.99) < 0.001 0.08 (−0.15–0.32) 0.487
≥ 65 years 0.74 (0.58–0.91) 0.004
IPAQ
< 65 years 0.80 (0.63–0.97) < 0.001 0.06 (−0.27–0.15) 0.549
≥ 65 years 0.87 (0.75–0.99) < 0.001
FES
< 65 years 0.87 (0.76–0.98) < 0.001 0.02 (−0.16–0.19) 0.853
≥ 65 years 0.85 (0.72–0.99) < 0.001
Abbreviations: AUC Area under the curve, ΔAUC Difference in area under the
curve, CI Confidence interval, TUG Timed up and go test, STS-5 Five-seconds sit
to stand test, SF-36 PF Physical function score of SF-36 questionnaire, SF-36
PCS Physical composite scale of SF-36 questionnaire, IPAQ International
physical activity questionnaire (short format), FES Tinetti falls efficacy scale
Table 4 Diagnostic accuracy of screening tools to expedite assessment of fall-risk in people receiving haemodialysis
Screening tools AUC (95% CI) P-value Gini-I K-S Cut-off Prevalence, n (%) SENS SPEC PPV NPV LR+ LR-
Handgrip (Kg) 0.67 (0.54–0.79) 0.009 0.33 0.34 ≤ 28.5 46 (60.5) 55% 79% 0.67 0.69 2.58 0.57
Gait speed (m/s) 0.65 (0.52–0.78) 0.021 0.31 0.32 ≤ 0.75 27 (36) 79% 53% 0.56 0.77 1.68 0.40
TUG (s) 0.66 (0.53–0.79) 0.015 0.32 0.30 ≥ 10.7 31 (41.9) 58% 71% 0.60 0.70 2.03 0.59
STS-5 (s) 0.57 (0.43–0.71) 0.348 0.14 0.25 ≥ 20.3 18 (25.4) 39% 86% 0.65 0.68 2.75 0.71
SF-36 PF (score) 0.69 (0.57–0.81) 0.002 0.38 0.33 ≤ 27.5 25 (33.8) 81% 52% 0.56 0.79 1.67 0.37
SF-36 PCS (score) 0.66 (0.54–0.79) 0.011 0.33 0.31 ≤ 32.9 30 (41.1) 73% 58% 0.57 0.74 1.75 0.46
IPAQ (METs/min/week) 0.54 (0.41–0.67) 0.528 0.08 0.14 ≤ 1243 61 (80.2) 26% 88% 0.63 0.60 2.17 0.84
FES (score) 0.80 (0.69–0.90) < 0.001 0.59 0.53 ≥ 18 40 (52.6) 82% 71% 0.69 0.83 2.86 0.25
Abbreviations: AUC Area under the curve, CI Confidence interval, Gini-I Gini Index, K-S KS statistic, SENS Sensitivity, SPEC Specificity, PPV Positive predictive value,
NPV Negative predictive value, LR+ Positive likelihood ratio, LR- Negative likelihood ratio, TUG Timed up and go test, STS-5 Five-seconds sit to stand test, SF-36 PF
Physical function score of SF-36 questionnaire, SF-36 PCS Physical composite scale of SF-36 questionnaire, IPAQ International physical activity questionnaire (short
format), FES Tinetti falls efficacy scale
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elderly (≥ 65 years-old) patients. Compared to self-
selected walking speed, the TUG evaluates more compo-
nents of physical function such as adequate muscle
strength (required to stand up from a chair), ambulation
and dynamic balance (required for walking and turning),
all of which are negatively affected by aging [45]. It is
therefore possible that TUG performance may be more
accurate in identifying both the true positives and nega-
tives in the elderly. Interestingly, gait speed, TUG and
STS-5 seemed to perform better than the self-reported
definition of frailty proposed by Johansen et al., [16], an
adaptation of the Fried phenotype based on four (instead
of five) criteria. In their study, Johansen et al., [16] re-
ported that such operationalisation of frailty had excel-
lent sensitivity (90%) and NPV (0.93) but only fair
specificity (64%) and poor PPV (0.54). From a practical
standpoint, the physical performance-based tests exam-
ined in our study would offer a more advantageous bal-
ance in terms of PPV and NPV while being less time
intensive than the self-reported definition. Notably, we
observed that a cut-off value of the SF-36 PF ≤ 43 had
the best sensitivity-specificity trade-off (Table 2). This
contrasted with the cut-off value utilised by Johansen
et al., [16] (SF-36 PF < 75), which may explain why their
self-report definition of frailty tends to overestimate
frailty prevalence [12, 16].
While physical performance tests such as gait speed,
TUG and STS-5 could accurately discriminate frailty sta-
tus, they only exhibited poor to fair accuracy for fall-risk
screening (Table 4). Notably, the Fried phenotype did
not discriminate fall-risk in our sample, which chal-
lenges the suitability of this frailty assessment as a po-
tential gold standard in HD populations. Indeed, some
researchers have postulated that some components of
the Fried phenotype may not effectively characterise true
physiological impairments in people receiving HD. For
instance, the unintentional weight loss component may
be biased by the fluid shifts at dialysis initiation and by
the decreased susceptibility to weight loss in the later
stages of CKD-5-HD [41, 46]. This potential confounder
could partially explain the lack of diagnostic perform-
ance of the Fried phenotype in the study population.
Since falls are one of the primary frailty-related out-
comes in CKD-5 [10, 47], identifying screening tools that
can effectively predict both frailty and fall-risk is para-
mount in a clinical setting, wherein time and resources
constraints often make it unpractical to administer mul-
tiple screening tests. In this regard, the Tinetti FES was
the only tool showing good diagnostic accuracy for
frailty (AUC = 0.84 [95%CI: 0.74–0.94]) and fall-risk
screening (AUC = 0.80 [95%CI: 0.69–0.90]) in our study.
In addition, this questionnaire performed well as a frailty
screener regardless of age, as evidenced by the high
AUC values in the ROC analysis categorised by age
(Table 3). Therefore, the Tinetti FES may be a valuable
tool for clinicians as it combines expediency of frailty
screening with useful prognostic information on fall-risk.
The Tinetti FES would also have the advantage of not
requiring physical testing, which is often a valued feature
in clinical settings [16]. Nevertheless, walking-related
measures such as gait speed and TUG can also be easily
implemented in a clinical setting as they are time/cost
effective and require minimal training (of the assessor),
resources and patient burden. Additionally, walking
speed is an established predictor of mortality in CKD
populations [41, 48]. Thus, tests based on walking per-
formance seem to have high overall clinical utility and
findings from this investigation strongly suggest that gait
speed and TUG are useful frailty screening tools in
people receiving HD.
Some strengths and limitations of this study should be
carefully examined when interpreting our findings. On
the one hand, all frailty-related assessments were con-
ducted by a single researcher on non-dialysis days, which
represents a strength in terms of standardisation proce-
dures and potential comparability within the study
population. On the other hand, the achieved sample was
relatively small (76 participants), which limits the statis-
tical power to detect small sub-group (i.e. age < or ≥ 65
years) effects. In particular, the identification of appro-
priate cut-offs and their sensitivity/specificity in different
age categories would benefit from inclusion of a larger
sample. Analogously, due to the modest sample size we
could not explore the association between screening
tools and mortality. In addition, the convenience sample
used in this study could be subjected to selection bias,
which may limit the generalisability of findings to the
entire CKD-5 population. We should also acknowledge
that, due to the physical nature of some of the screening
tests employed in the study, we limited our inclusion cri-
teria to participants who had sufficient physical function
to perform these tests. The exclusion of more physically
impaired patients might have impacted the observed
prevalence of frailty as well as the cut-off values identi-
fied in ROC analysis. Lastly, the prevalence of frailty
may also have been affected by the fact that we replaced
the frailty phenotype exhaustion component [1] with the
exhaustion criteria proposed by Johansen et al. [25].
Conclusions
The current study revealed that different time-efficient
screening tools involving either physical performance
tests or short questionnaires can be used to assess frailty
in people receiving HD. Among the examined tools,
walking performance measures such as gait speed and
TUG exhibited the highest diagnostic accuracy using the
Fried phenotype as the reference standard. While gait
speed had an excellent diagnostic performance in people
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under 65 years of age, the TUG may be a more appropri-
ate screening method for elderly patients (≥ 65 years-
old). Importantly, the Tinetti FES was the only measure
showing good diagnostic accuracy for both frailty and
fall-risk screening. The instruments examined in this
study could be used to evaluate whether patients may
benefit from a comprehensive geriatric assessment. In
this regard, further research would be required to ex-
plore the diagnostic accuracy of walking performance
measures by utilising a geriatric assessment as the refer-
ence standard. Ultimately, multiple independent studies
may be needed to fathom which screening tools should
be incorporated into clinical practice for routine frailty-
screening in the dialysis unit.
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